Everything You Need to Know About Krabbe Disease for Step 1
Krabbe disease is a high-yield lysosomal storage disorder that USMLE loves because it’s a clean test of: enzyme deficiency → toxic metabolite → characteristic cells → classic infantile presentation.
Quick Definition (Step 1–Style)
Krabbe disease (Globoid cell leukodystrophy) is an autosomal recessive lysosomal storage disease caused by galactocerebrosidase (GALC) deficiency, leading to demyelination in the CNS and PNS.
Classic buzzwords:
- GALC deficiency
- ↑ Galactocerebroside and psychosine
- Globoid cells
- Peripheral neuropathy + central demyelination
- Infant with developmental delay + hypertonia
Where It Fits (Biochem Framework)
Lysosomal Storage Diseases: What Step 1 Wants
Lysosomes degrade complex lipids and carbohydrates. When a lysosomal enzyme is missing:
- Substrate accumulates in cells (often macrophages and oligodendrocytes)
- Tissues with high lipid turnover (especially myelin) get hit hard
Krabbe is grouped with sphingolipidoses and leukodystrophies because it affects myelin.
Pathophysiology: The Core Mechanism
Enzyme Deficiency
- Galactocerebrosidase (GALC) deficiency
Accumulating Molecules
- Galactocerebroside (a major myelin component)
- Psychosine (galactosylsphingosine) — particularly toxic to oligodendrocytes
Why Demyelination Happens
- Psychosine is directly toxic → oligodendrocyte death
- Loss of oligodendrocytes → severe demyelination
- Demyelination occurs in:
- CNS (white matter) → developmental regression, seizures
- PNS → peripheral neuropathy
Histology (Very Testable)
- “Globoid cells” = multinucleated macrophages stuffed with galactocerebroside
These appear in white matter as myelin breaks down.
Clinical Presentation (What You’re Expected to Recognize)
Typical Onset
- Most commonly infantile onset (often within first few months of life)
High-Yield Symptoms
Neuro + myelin failure picture:
- Developmental delay/regression
- Irritability
- Hypertonia and spasticity
- Seizures
- Peripheral neuropathy (often emphasized for Krabbe vs some other leukodystrophies)
- Optic atrophy may occur → visual impairment
Distinguishing Pattern
Krabbe often presents as:
- Infant with progressive neurologic decline + hypertonia + demyelination
- Compared with metachromatic leukodystrophy (see below), Krabbe is classically linked to globoid cells and GALC deficiency.
Diagnosis (Step 1 Priorities)
1) Enzyme Assay (Best Board-Style Answer)
- Low GALC activity in leukocytes or cultured fibroblasts
2) Genetic Testing
- GALC gene mutation confirmation and family counseling
3) Supportive Findings
- MRI brain: leukodystrophy pattern (white matter abnormalities)
- Nerve conduction studies: peripheral demyelinating neuropathy
Histologic Clue
- Globoid cells (multinucleated macrophages) in white matter
Treatment (Know the “If Early” Rule)
Disease-Modifying (Time-Sensitive)
- Hematopoietic stem cell transplant (HSCT) (including umbilical cord blood transplant)
- Most beneficial if performed pre-symptomatically or very early
- Rationale: donor-derived microglia/macrophages can supply enzyme activity in CNS
Supportive Care
- Seizure control
- Spasticity management
- Nutritional and respiratory support
- Multidisciplinary palliative care in advanced cases
Prognosis: Infantile Krabbe is often severe and progressive; early transplant can slow progression but is not a universal cure.
High-Yield Associations & Differentials (Rapid-Fire)
Krabbe vs Metachromatic Leukodystrophy (MLD)
Both are leukodystrophies with demyelination, but:
Krabbe
- Enzyme: GALC
- Accumulates: galactocerebroside + psychosine
- Cells: globoid cells
- Often: hypertonia, peripheral neuropathy, developmental regression
Metachromatic leukodystrophy
- Enzyme: arylsulfatase A
- Accumulates: cerebroside sulfate
- Often: ataxia, dementia, peripheral neuropathy
- “Metachromatic” refers to staining properties of accumulated sulfatides
Krabbe vs Tay-Sachs (classic Step 1 contrast)
Tay-Sachs
- Enzyme: Hexosaminidase A
- Accumulates: GM2 ganglioside
- Key: cherry-red macula, no hepatosplenomegaly
Krabbe
- Demyelination + globoid cells
- Peripheral neuropathy is more emphasized
Inheritance Pattern
- Autosomal recessive (memorize with most lysosomal storage diseases)
Board-Style Memory Hooks (Clean and Safe)
- Krabbe = GALC gone bad → Globoid cells
- Psychosine is poisonous → oligodendrocytes die → demyelination
- Infantile neurodegeneration + hypertonia + peripheral neuropathy
First Aid Cross-References (Where to Find It)
In First Aid for the USMLE Step 1, Krabbe disease is covered in the Biochemistry chapter under:
- Lysosomal storage diseases
- Often in a table alongside: Tay-Sachs, Gaucher, Niemann-Pick, Fabry, Hunter/Hurler, Pompe, and metachromatic leukodystrophy
Look for keywords: GALC, globoid cells, psychosine, peripheral neuropathy.
(Edition layouts vary, but it’s reliably in the lysosomal storage disease table in Biochemistry.)
Ultra–High-Yield Summary (What to Write on Your Scratch Paper)
- Dx: AR lysosomal storage disease
- Enzyme: ↓ Galactocerebrosidase (GALC)
- Substrate: ↑ Galactocerebroside + psychosine
- Path: psychosine toxic → oligodendrocyte loss → demyelination (CNS + PNS)
- Histology: globoid cells (multinucleated macrophages)
- Clinical: infantile onset, developmental regression, hypertonia, seizures, peripheral neuropathy
- Tx: HSCT early + supportive care
Frequently Asked Questions
Why does Krabbe disease cause severe demyelination in both the CNS and PNS?
Krabbe disease causes demyelination because galactocerebrosidase deficiency leads to buildup of galactocerebroside and psychosine, and psychosine is particularly toxic to oligodendrocytes. Oligodendrocyte death leads to severe loss of myelin, affecting CNS white matter and the peripheral nervous system. This explains the combination of central neurologic decline with peripheral neuropathy in the classic infantile presentation.
How do you tell Krabbe disease from metachromatic leukodystrophy on Step 1?
The key way to distinguish Krabbe disease is by GALC deficiency, accumulation of galactocerebroside and psychosine, and the presence of globoid cells. Krabbe is often associated with hypertonia, peripheral neuropathy, and developmental regression. Metachromatic leukodystrophy instead involves arylsulfatase A deficiency with cerebroside sulfate accumulation and is classically linked to ataxia, dementia, and metachromatic staining of sulfatides.
What is the classic infant presentation of Krabbe disease?
The classic presentation is an infant with progressive neurologic decline, developmental delay or regression, and hypertonia. Krabbe disease commonly begins within the first few months of life and may also feature irritability, spasticity, seizures, peripheral neuropathy, and sometimes optic atrophy with visual impairment. This pattern reflects widespread demyelination in both the central and peripheral nervous systems.
What is the best board-style test to diagnose Krabbe disease?
The best board-style diagnostic test is an enzyme assay showing low galactocerebrosidase activity in leukocytes or cultured fibroblasts. Genetic testing can then confirm a GALC mutation and help with family counseling. Supportive findings may include MRI evidence of leukodystrophy, nerve conduction studies showing peripheral demyelinating neuropathy, and histology with multinucleated globoid cells in white matter.
What is the first-line disease-modifying treatment for Krabbe disease?
The main disease-modifying treatment is hematopoietic stem cell transplant, including umbilical cord blood transplant, performed before symptoms begin or very early in the disease. It is most beneficial when done early because donor-derived microglia and macrophages can provide enzyme activity in the CNS. Supportive care still remains important for seizures, spasticity, nutrition, respiratory needs, and advanced disease.